Behavior Change Program to Promote Physical Activity in People Newly Diagnosed with MS
Researchers at the University of Alabama at Birmingham are conducting a behavior change intervention to promote lifestyle physical activity among persons diagnosed with MS within the last 2 years.
Read more
Detecting Early Signs of Cognitive Problems (New York)
Researchers at NYU Langone Health, Multiple Sclerosis Comprehensive Care Center, are partnering with individuals like you to discover ways to detect early signs of cognitive problems.
• We are recruiting individuals with an early diagnosis of, or at-risk, of developing MS.
• The research study consists of a single visit at the NYU Multiple Sclerosis Comprehensive Care Center.
• Participants will complete an MRI scan and a series of cognitive assessments, questionnaires, and an optional gait (walking) assessment.
• All study procedures are completed during a one-time visit.
• Compensation can be up to $125 for your time.
Participation in our research study is completely voluntary, free, and confidential.
For more information regarding enrollment, please contact us at 929-455-5090 or email us at
NYUMSresearch@nyulangone.org
Trial of Treatment Strategies to Prevent Disability - TREAT MS
A study based at Johns Hopkins University is comparing two treatment strategies in 900 people newly diagnosed with relapsing-remitting MS, or with onset/diagnosis of relapsing-remitting MS in the past who have received minimal or no treatment. The study is recruiting at approximately 45 centers nationwide. One option is an escalation approach, in which people start taking a less powerful therapy with the option of switching to a more potent therapy if disease activity continues. The other approach involves starting with a stronger therapy that is potentially more effective, but also carries the potential for greater risk for significant adverse effects. The “TRaditional versus Early Aggressive Therapy for Multiple Sclerosis” (TREAT-MS) Trial is funded by the Patient-Centered Outcomes Research Institute (PCORI).
Read more and participate
Trial of Treatment Strategies to Prevent Disability - DELIVER MS
A study based at the Cleveland Clinic and the University of Nottingham (United Kingdom) is comparing two treatment strategies in 800 people with relapsing-remitting MS diagnosed within the past five years who have never taken a disease-modifying therapy. The study is recruiting at 30 centers in the United States and United Kingdom. One strategy is an “escalation” approach, in which individuals start taking a less-powerful therapy with the option of switching to a more potent one if disease activity continues. The other strategy involves starting with a strong therapy that is potentially more effective, but also carries greater risk for significant adverse effects. The “Determining the Effectiveness of Early Intensive versus Escalation Approaches for the Treatment of Relapsing-Remitting Multiple Sclerosis” (DELIVER-MS) Trial is funded by the Patient-Centered Outcomes Research Institute (PCORI).
Read more and participate